• Archives of Pharmacal Research
• /
• 제18권6호
• /
• pp.381-384
• /
• 1995

Covalent binding of the reactive metabolites of SC_42867 to microsomal proteins has been examined. In the absence of inhibitor of cytochrome oxydase (.alpha.-naphtyl-isothiocyanate) or a radical scavenger (3-terthiobuty-4-hydroxyanisol), up to 4.0% of total redioactivity used in the assay could irreversibly bind to proteins. In the presence of an inhibitor, the highest percentage of covalent binding observed is 0.7% a significant decrease of the metabolism of SC42876 was observed. These results suggest in a cytochrome P-450 dependent generation of SC_42867 metabolites significantly take part in the covalent binding process.

• Biomolecules & Therapeutics
• /
• 제21권6호
• /
• pp.487-492
• /
• 2013

Cytochrome P450 4A11 (CYP4A11) is a fatty acid hydroxylase enzyme expressed in human liver. It catalyzes not only the hydroxylation of saturated and unsaturated fatty acids, but the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), a regulator of blood pressure. In this study, we performed a directed evolution analysis of CYP4A11 using the luminogenic assay system. A random mutant library of CYP4A11, in which mutations were made throughout the entire coding region, was screened with luciferase activity to detect the demethylation of luciferin-4A (2-[6-methoxyquinolin-2-yl]-4,5-dihydrothiazole-4-carboxylic acid) of CYP4A11 mutants in Escherichia coli. Consecutive rounds of random mutagenesis and screening yielded three improved CYP4A11 mutants, CP2600 (A24T/T263A), CP2601 (T263A), and CP2616 (A24T/T263A/V430E) with ~3-fold increase in whole cells and >10-fold increase in purified proteins on the luminescence assay. However, the steady state kinetic analysis for lauric acid hydroxylation showed the significant reductions in enzymatic activities in all three mutants. A mutant, CP2600, showed a 51% decrease in catalytic efficiency ($k_{cat}/K_m$) for lauric acid hydroxylation mainly due to an increase in $K_m$. CP2601 and CP2616 showed much greater reductions (>75%) in the catalytic efficiency due to both a decrease in $k_{cat}$ and an increase in Km. These decreased catalytic activities of CP2601 and CP2616 can be partially attributed to the changes in substrate affinities. These results suggest that the enzymatic activities of CYP4A11 mutants selected from directed evolution using a luminogenic P450 substrate may not demonstrate a direct correlation with the hydroxylation activities of lauric acid.

• Journal of Applied Biological Chemistry
• /
• 제43권1호
• /
• pp.49-53
• /
• 2000

The in vitro metabolism of a new herbicide pyribenzoxim, {benzophenone O-[2,6-bis[(4,6-dimethoxy-2-pyrimidinyl)oxy]benzoyl]oxime} was studied using rice, barnyardgrass and rat liver microsomes. No metabolism of pyribenzoxim was observed with rice and barnyardgrass microsomes though the cvtochrome P450 was active, which was evidenced by the metabolism of cinnamic acid. With rat liver microsomes, four metabolites (M1, M2, M3, and M4) were produced while parent compound decreased. M1 and M2 were from the hydrolysis reactions and NADPH-dependent metabolites were M3 and M4 (major metabolite) which were hydroxylated by cytochrome P450. They were identified as bispyribac-sodium (M1), benzophenone oxime (M2), {benzophenone O-[2,6-bis[(5-hydroxy-4,6-dimethoxy-2-pyrimidinyl)oxy]-benzoyl]oxime}(M3), and {benzophenone O-[2[(5-hydroxy-4,6-dimethoxy-2l-pyrimidinyl)6-(4,.6dimethoxy-2-pyrimidinyl)oxy]benzoyl]oxime} (M4) through LC/MS/MS analyses. Based on the results obtained metabolic map of pyribenzoxim is proposed.

• 대한한의학회지
• /
• 제35권2호
• /
• pp.47-59
• /
• 2014

Objectives: Most drug interactions are attributed to the inhibition or induction of the activity of cytochrome P450s (CYP450). Although the regulation of CYP450s by drugs has been widely reported, there have been few studies on influence of traditional herbal formulas on the drug-metabolizing enzymes. Because herbal formulas have been used traditionally to treat various diseases and because herb-drug interactions are crucial factors determining therapeutic efficacies, a systematic evaluation of the effects of herbal formulas is important. Methods: The effects of Galgeun-tang (GGT, gegen tang), Gumiganghwal-tang (GMGHT, jiuweiqianghuo tang), Insampaedok-san (ISPDS, renshenbaidu powder), Samsoeum (SSE, shensu drink), Socheongryong-tang (SCRT, xiaoqinglong-tang) and Sosiho-tang (SSHT, xiaochaihu tang) that are traditional herbal formulas used to treat common cold, on drug-metabolizing enzymes were evaluated through an in vitro CYP3A4, CYP2D6, CYP2C19 and CYP2E1 inhibition assay to assess its interaction potential with synthetic drugs. The inhibitory effects of herbal formulas were characterized with $IC_{50}$ values. Results: These six herbal formulas inhibited the activities of CYP3A4, 2C19, 2D6 and 2E1, in a concentration-dependent manner. Among the six herbal formulas, GGT critically inhibited CYP2C19, CYP2D6 and CYP2E1. GMGHT also inhibited CYP2D6 and CYP2E1 to a greater extent than the other CYP450 isozymes. Additionally, SSE and SSHT may change the effects of medicines that depend primarily on the CYP2C19 and CYP2E1 pathways. On the other hand, ISPDS and SCRT were not inhibited CYP3A4, CYP2C19, CYP2D6 and CYP2E1-mediated metabolism. Conclusions: These findings provide useful information regarding the safety and effectiveness of herbal formulas.

• 생명과학회지
• /
• 제22권7호
• /
• pp.880-888
• /
• 2012

본 연구는 산란계 사료 내 항균성장촉진제로써 돼지감자(Helianthus tuberosus L.)로부터 추출, 제조한 이눌로프리바이오틱스(Inuloprebiotics, INP)의 고수준 첨가가 산란능력 및 계란품질에 미치는 영향을 조사하기 위해 실시하였다. 29주령의 갈색산란계(Hyline brown) 320마리를 이용하여 처리구당 80마리씩 개체별, 반복구로 나누어서 완전임의 배치한 후 10주 동안 실험사료를 급여하였다. 실험처리구는 T1 (무첨가 대조군), T2 (INP 450 ppm 첨가군), T3 (INP 600 ppm 첨가군) 및 T4 (INP 750 ppm 첨가군)로 구분하였다. 산란율, 난중, 사료섭취량 및 계란의 호우유니트, 난각두께, 파란강도는 T1과 비교할 때 T2, T3, T4가 유의하게 높았으나(p<0.05) T2, T3, T4 사이의 통계적인 유의차는 인정되지 않았다. 계란의 콜레스테롤은 T1이 가장 높았고 T4, T3, T2 순서로 이눌로프리바이오틱스 첨가구에서 15.04-17.98%까지 유의하게 감소하였다(p<0.05). 계란 포화지방산 조성은 T2, T3, T4가 T1에 비해서 낮았으나 불포화지방산은 그 반대로 유의하게 높았다(p<0.05). 혈액 중성지방 및 총콜레스테롤은 T1과 비교할 때 T2, T3, T4에서 21.71-24.07% 및 27.17-30.36%로 유의하게 감소하였다(p<0.05). 맹장의 유익한 미생물, Bifidobacterium, Lactobacillus의 성장은 T2, T3, T4가 T1과 비교할 때 자극되었으나 유해한 Escherichia, Salmonella의 성장은 뚜렷하게 억제되었다(p<0.05). 본 연구결과는 이눌로프리바이오틱스 450 ppm을 산란계 사료 내 첨가해주면 산란성적 및 계란품질을 향상시킬 수 있음을 시사해준다.

• Asian-Australasian Journal of Animal Sciences
• /
• 제22권5호
• /
• pp.618-625
• /
• 2009

The objective of this work was to study the direct effects of daidzein on steroidogenesis in cultured mouse Leydig cells. Adult mouse Leydig cells were purified by Percoll gradient centrifugation, and the cell purity was determined using a $3{\beta}$-hydroxysteroid dehydrogenase ($3{\beta}$-HSD) staining method. The purified Leydig cells were exposed to different concentrations ($10^{-7}$ M to $10^{-4}$ M) of daidzein for 24 h under basal and human chorionic gonadotropin (hCG)-stimulated conditions. The cell viability and testosterone production were determined, and the related mechanisms of daidzein action were also evaluated using the estrogen receptor antagonist ICI 182,780 and measuring the mRNA levels of steroidogenic acute regulatory protein (StAR), cholesterol side-chain cleavage enzyme (P450scc), and $3{\beta}$-HSD-1 involved in testosterone biosynthesis. The results revealed that daidzein did not influence cell viability. Daidzein increased both basal and hCG-stimulated testosterone production in a dose-dependent manner, and this effect was statistically significant at concentrations of $10^{-5}$ M and $10^{-4}$ M daidzein (p<0.05). ICI 182,780 had no influence on daidzein action. RTPCR results revealed that $10^{-5}$ M and $10^{-4}$ M daidzein did not exert any obvious influence on the mRNA level of P450scc in Leydig cells. However, in the presence of hCG, these concentrations of daidzein significantly increased the StAR and $3{\beta}$-HSD-1 mRNA levels (p<0.05), but in the absence of hCG, only $10^{-5}$ M and $10^{-4}$ M daidzein up-regulated the StAR and $3{\beta}$-HSD-1 mRNA expression (p<0.05), respectively. These results suggest that daidzein has direct effect on Leydig cells. Daidzein-induced increase of testosterone production is probably not mediated by the estrogen receptor but correlates with the increased mRNA levels of StAR and $3{\beta}$-HSD-1.

• Mass Spectrometry Letters
• /
• 제14권3호
• /
• pp.116-119
• /
• 2023

Gynostemma pentaphyllum (Thunb.) Makino extract, a natural product with a history of traditional use, has gained attention for its potential health benefits. This study aimed to investigate its effects on key cytochrome P450 (CYP) enzymes using LC-MS/MS. Human liver microsomes and cDNA-expressed CYP2C8, CYP2C9, CYP2C19, and CYP3A4 supersomes were employed. Enzyme activity was assessed based on the formation of CYP-specific marker metabolites. The resulting data showed that the extract exhibited inhibitory effects on CYP2C8, CYP2C9, CYP2C19, and CYP3A4. Thus, G. pentaphyllum extract may influence the pharmacokinetics of drugs metabolized by CYP2C8, CYP2C9, CYP2C19, and CYP3A4. These findings emphasize the importance of considering potential herb-drug interactions when incorporating this extract into therapeutic regimens or dietary supplements.

• 생명과학회지
• /
• 제8권5호
• /
• pp.604-613
• /
• 1998

담배의 phytoalexin으로 알려진 capsidiol 생합성의 마지막 단계에 관여하는 5-epi-aristolochene hydroxy-lase 유전자의 일부를 RT-PCR 방법으로 클로닝하였다. 클로닝한 CYP-B3는 콩, 완두 등의 cytochrome P450계의 유전자와 높은 동일성을 보였으며 heme 결합부위로 알려진 FxxGxRxCxG을 포함하고 있는 것으로 나타났다. 또한 CYP-B3는 저온, 고온 또는 제초제 등에 의해서는 유도되지 않고 Elicitor에 의해서만 특이하게 유도되는 것으로 나타나 Phytoalexin 생합성에 관여하는 유전자임을 확인하였다. Cyt P450 억제제인 ancy-midol과 ketoconazol에 의해 CYP-B3의 전사는 억제되지 않는 반면 5-epi-aristolochene hydroxylase의 효소활성은 현저히 억제되는 것으로 나타나 이들 억제제는 전사후의 효소의 합성 또는 활성을 억제하는 것으로 나타났다.

• 마이크로전자및패키징학회지
• /
• 제6권4호
• /
• pp.55-59
• /
• 1999

전자 패키징에 적용 가능한 납성분이 포함되어 있지 않는 Bi계저융점유리의 연구를 행하였다. Bi계유리중, 70wt% $Bi_2O_3$+ l5wt% $B_2O_3$ + 8wt% $SiO_2$+ 2wt% $P_2O_5$ + 4wt% $A1_2O_3$ + lwt%ZnO 성분의 유리는 융점이 약 $550^{\circ}C$ 였으며, $P_2O_5$의 함량에 따라서 그 융점이 변화하였다. 10wt%이상의 $P_2O_5$ 첨가에서는 $450^{\circ}C$의 열처리로 결정화가 진행되었다. $B_2O_3$가 많이 함유된 조성의 유리에서는 그 융점이 상승하였다.

• Archives of Pharmacal Research
• /
• 제26권8호
• /
• pp.631-637
• /
• 2003

Chloroquine has been used for many decades in the prophylaxis and treatment of malaria. It is metabolized in humans through the N-dealkylation pathway, to desethylchloroquine (DCQ) and bisdesethylchloroquine (BDCQ), by cytochrome P450 (CYP). However, until recently, no data are available on the metabolic pathway of chloroquine. Therefore, the metabolic pathway of chloroquine was evaluated using human liver microsomes and cDNA-expressed CYPs. Chloroquine is mainly metabolized to DCQ, and its Eadie-Hofstee plots were biphasic, indicating the involvement of multiple enzymes, with apparent $K_m and V_{max}$ values of 0.21 mM and 1.02 nmol/min/mg protein 3.43 mM and 10.47 nmol/min/mg protein for high and low affinity components, respectively. Of the cDNA-expressing CYPs examined, CYP1A2, 2C8, 2C19, 2D6 and 3A4/5 exhibited significant DCQ formation. A study using chemical inhibitors showed only quercetin (a CYP2C8 inhibitor) and ketoconazole (a CYP3A4/5 inhibitor) inhibited the DCQ formation. In addition, the DCQ formation significantly correlated with the CYP3A4/5-catalyzed midazolam 1-hydroxylation (r=0.868) and CYP2C8-catalyzed paclitaxel 6$\alpha$-hydroxylation (r = 0.900). In conclusion, the results of the present study demonstrated that CYP2C8 and CYP3A4/5 are the major enzymes responsible for the chloroquine N-deethylation to DCQ in human liver microsomes.